Recent Updates
Recently added Catalysts
AMGN

Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference Amgen (NASDAQ:AMGN) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 13, 2012, in London,...

Key Takeaway: THOUSAND OAKS, Calif. , Sept. 10, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 13, 2012 , in London , beginning at 9:50 a.m. Greenwich Mean Time. Arvind Sood, vice president of Inv

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , Sept. 10, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 13, 2012 , in London , beginning at 9:50 a.m. Greenwich Mean Time. Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Eric Hyllengren , 805-447-1060 (investors)
Last updated: Sep 10, 2012